Trends in the management and burden of alcoholic liver disease

Slides:



Advertisements
Similar presentations
Christopher Berlin // März 2015 A Histologic Scoring System for Prognosis of Patients with Alcoholic Hepatitis Altamirano et.al., Gastroenterology 2014.
Advertisements

FT in prognostic of HBV FibroTest: predictive value in HBV.
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Volume 42, Issue 4, Pages (April 2005)
Inflammasomes in liver diseases
Volume 67, Issue 3, Pages (September 2017)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Volume 143, Issue 4, Pages e14 (October 2012)
Global trends and predictions in hepatocellular carcinoma mortality
Volume 42, Issue 6, Pages (June 2005)
Primary prevention of variceal haemorrhage: A pharmacological approach
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Non-invasive diagnosis of non-alcoholic fatty liver disease
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Volume 66, Issue 1, Pages 1-4 (January 2017)
Volume 69, Issue 1, Pages (July 2018)
Grand Rounds: Alcoholic Hepatitis
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Liver cancer: Approaching a personalized care
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 54, Issue 5, Pages (May 2011)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 58, Issue 3, Pages (March 2013)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Volume 57, Issue 4, Pages (October 2012)
Autophagy in the liver Journal of Hepatology
Volume 66, Issue 2, Pages (February 2017)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Clinical states of cirrhosis and competing risks
Volume 69, Issue 3, Pages (September 2018)
Reply to: “It takes two “eyes” to see in depth”
Theresa Hydes, William Gilmore, Nick Sheron, Ian Gilmore 
Volume 50, Issue 4, Pages (April 2009)
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 61, Issue 1, Pages S79-S90 (November 2014)
Chetana Lim, Chady Salloum, Daniel Azoulay
Evolution of liver transplantation for hepatocellular carcinoma
Global burden of alcoholic liver diseases
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
The use of hemospray in portal hypertensive bleeding; a case series
Volume 66, Issue 3, Pages (March 2017)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
The metabolomic window into hepatobiliary disease
Genetics of hepatocellular carcinoma: The next generation
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Outcomes in liver transplantation: Does sex matter?
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Trends in the management and burden of alcoholic liver disease Philippe Mathurin, Ramon Bataller  Journal of Hepatology  Volume 62, Issue 1, Pages S38-S46 (April 2015) DOI: 10.1016/j.jhep.2015.03.006 Copyright © 2015 Terms and Conditions

Fig. 1 Relationship between standard liver death rate and overall alcohol consumption in several European countries. The relationship between standard liver death rate (SDR) (per 100,000) and overall alcohol consumption (pure alcohol litres per capita, age 15+) in the four countries in the EU (pre-2004) with the largest rises or falls in liver deaths between 1970 and 2008. Data from the World Health Organization, European Health for All database (HFA-DB): http://data.euro.who.int/hfadb/. Reproduced with permission from [17]. Journal of Hepatology 2015 62, S38-S46DOI: (10.1016/j.jhep.2015.03.006) Copyright © 2015 Terms and Conditions

Fig. 2 Natural history of alcoholic liver disease from steatosis to cirrhosis and hepatocellular carcinoma (HCC). The percentage represents the patients who progress from one stage to the next. Most patients with persistent alcohol abuse develop some degree of hepatic steatosis. If the alcohol abuse persists, liver fibrosis progressively develops, ultimately resulting in cirrhosis. Cirrhosis can lead to severe complications related to portal hypertension (ascites, variceal bleeding and encephalopathy), bacterial infections and also predisposes to HCC. The development of alcoholic steatohepatitis (ASH) predisposes patients to progress to advanced liver fibrosis, and when this develops in patients with severe disease it results in AH. Journal of Hepatology 2015 62, S38-S46DOI: (10.1016/j.jhep.2015.03.006) Copyright © 2015 Terms and Conditions

Fig. 3 The Alcoholic Hepatitis Histological Score (AHHS) allows prognostic stratification of patients with biopsy-proven AH. AHHS categories are as follows: mild, 0–3; intermediate, 4–5; severe, 6–9. The Kaplan-Maier graph shows 90-day survival in each the three categories. Reproduced with permission from [47]. Journal of Hepatology 2015 62, S38-S46DOI: (10.1016/j.jhep.2015.03.006) Copyright © 2015 Terms and Conditions